海洋生物产业发展创新平台建设的对策OA
Countermeasures for Construction of Industrialized Innovation Platforms:take Xiamen as an example
海洋药物和生物制品产业是国家重点培育的海洋战略性新兴产业之一,产业的发展离不开一流的产业发展创新平台的科技支撑,目前我国海洋药物和生物制品产业尚缺乏一支以成果转化与产业化为目标的强有力的国家科技力量支撑.文章通过调研全国海洋生物领域产业发展创新平台建设的发展经验、存在问题,梳理在厦门建设海洋生物产业发展创新平台政策、科技、产业等资源现状,为在厦门布局海洋生物国家级产业发展创新平台提出优化体制机制、明确定位和"造血"能力、畅通人才交流和上升通道的建议,以提高创新转换效率,推动海洋药物和生物制品产业发展.
The marine pharmaceutical and biological product industry is one of the marine strate-gic emerging industries that China has cultivated.Its development cannot be separated from the scientific research support of first-class innovation platforms.Currently,China's marine phar-maceutical and biological product industry lacks a support of a strong national industrialized in-novation platform.This study investigates the development experience and existing problems of innovation platform in the marine pharmaceutical and biological product industry,and sorts out the policy,technology,and industry status in Xiamen for construction of industrialized innova-tion platforms,and puts forward countermeasures:optimize institutional mechanisms,clarify positioning and capabilities,facilitate talent exchange and upward channels for the layout of a national level innovation platform to promote the development of marine pharmaceutical and bi-ological product industry.
林逸君
自然资源部第三海洋研究所 厦门 361005
海洋学
海洋药物海洋生物制品科技创新产业发展创新平台科技成果转化
Marine drugsMarine biological productsScientific and technological innovationIndustrialized innovation platformTransformation of scientific and technological achievements
《海洋开发与管理》 2024 (004)
73-83 / 11
自然资源部"海洋经济高质量发展政策制定实施和监测评估"项目;福建省技术转移机构补助经费项目"技术创新服务体系"(KJTPT2022JSZY020032).
评论